RGC
NASDAQ · Pharmaceuticals
Regencell Bioscience Holding
$5.34
+0.07 (+1.33%)
Performance
1D
—
1W
-20.42%
1M
-24.89%
3M
+1.14%
6M
-80.46%
1Y
-59.73%
YTD
-74.00%
Open$5.36
Previous Close$5.27
Day High$5.49
Day Low$5.10
52W High$69.00
52W Low$4.51
Volume—
Avg Volume397.7K
Market Cap3.33B
P/E Ratio—
EPS$-0.02
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$6.86
Below
SMA 200
$16.83
Below
RSI (14)
24.6
Oversold
Trend
Death Cross
Bearish
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 3.66B | 3.76B | 3.59B |
| Net Income | 706.46M | 788.49M | 815.65M |
| Profit Margin | 19.3% | 21.0% | 22.7% |
| EBITDA | 1.06B | 1.04B | 1.04B |
| Free Cash Flow | 809.03M | 638.27M | 648.55M |
| Rev Growth | +1.6% | +15.1% | +20.8% |
| Debt/Equity | 0.23 | 0.28 | 0.31 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,368.84 | +0.30% | 50.2 | 1.34T |
| JNJ | Johnson & Johnson | $274.87 | +0.94% | 41.3 | 665.03B |
| MRK | Merck & Co. Inc. | $147.01 | +0.05% | 117.2 | 371.99B |
| PFE | Pfizer Inc. | $29.30 | -1.94% | 40.0 | 173.27B |
| BMY | Bristol-Myers Squibb Co | $62.89 | -0.38% | 13.8 | 128.00B |
| ZTS | Zoetis Inc | $79.81 | -2.80% | 12.3 | 32.24B |